Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2003
08/28/2003WO2003070709A1 Novel phenylalanine derivative
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070279A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070184A2 Sodium channel blockers
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003070155A2 Orally administrable pharmaceutical formulation
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003043986A8 Polypeptides of moraxella (branhamella) catarrhalis
08/28/2003WO2003041683A3 Orodispersible tablets containing fexofenadine
08/28/2003WO2003037384A3 Polymer conjugates of protein kinase c inhibitors
08/28/2003WO2003031447A3 Pyrimidine derivatives
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002077021A3 Streptococcus pneumoniae proteins and nucleic acids
08/28/2003WO2002041880A3 Use of pyrazolo[4,3-d]pyrimidines
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162835 Method of making particles for use in a pharmaceutical composition
08/28/2003US20030162808 Acetindine derivatives, their preparation and medicaments containing them
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162794 Benzazole derivatives and their use as jnk modulators
08/28/2003US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/28/2003US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162737 Preventives and remedies for pulmonary hypertension
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161899 For prophylaxis of inhalation allergic reactions comprising mixture of saturated hydrocarbons having viscosity of greater than 6 mm2/s123n; treatment of atopic rhinitis in the form of "hayfever"
08/28/2003US20030161884 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003US20030161845 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine
08/28/2003US20030161826 Therapy for autoimmune disease; central nervous system disorders
08/28/2003US20030161816 Systems and methods for treating patients with processed lipoaspirate cells
08/28/2003US20030161791 Water-soluble polymer conjugates of retinoic acid
08/28/2003CA2476854A1 Surrogate antibodies and methods of preparation and use thereof
08/28/2003CA2476837A1 Sodium channel blockers
08/28/2003CA2476822A1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003CA2476764A1 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003CA2476679A1 Vitamin d3 derivatives and remedies using the same
08/28/2003CA2476665A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475923A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337557A2 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
08/27/2003EP1337544A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337265A1 Methods of treatment comprising administration of substance p
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337250A2 Use of p38 inhibitors for the treatment of smoke inhalation
08/27/2003EP1337241A2 Pharmaceutical compositions for inhalation
08/27/2003EP1337240A2 Method of making particles for use in a pharmaceutical composition
08/27/2003EP1185540B1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents
08/27/2003EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids
08/27/2003EP1095039B1 New pharmaceutically active compounds
08/27/2003EP0936905B1 Immediate wettability water soluble film or water soluble layer for oral application
08/27/2003EP0906089B1 Buccal delivery system
08/27/2003EP0896525B1 Methods of dry powder inhalation
08/27/2003EP0862552B1 Succinimide and maleimide cytokine inhibitors
08/27/2003CN1439021A Parathyroid hormone and parathyroid hormone-related protein receptor modulators
08/27/2003CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group
08/27/2003CN1439017A Novel compounds
08/27/2003CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
08/27/2003CN1439009A Imidazo pyrimidine derivatives and triazolopyrimidine derivatives
08/27/2003CN1439003A Arylmethy lamine derivatives for use as tryptase inhibitors
08/27/2003CN1438999A Serine protease inhibitors
08/27/2003CN1438900A A Novel treatment for cough
08/27/2003CN1438890A 腺苷受体调制剂 Adenosine receptor modulators
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438884A Therapeutic combinations of fatty acids
1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 878